doi: 10.1210/jc.2011-3172 34 GregoryJMSmithTJSlaughterJCMasonHRHugheyCCSmithMSet al
Unlocking Sustainable Weight Loss with GLP1 Medications and Peptides at Illume Med Spa & Wellness Apr 18, 2025 2 min read In the evolving landscape of weight management, GLP-1 receptor agonists and peptides have emerged as transformative tools
Summary: There is currently no established scientific evidence linking Ozempic (semaglutide) to memory loss or cognitive decline in clinical trials
At this time, there is not enough scientific evidence to consider it safe for use during pregnancy or breastfeeding, so avoiding it during these stages is generally recommended
Research examines potential interactions between their absorption profiles, systemic biodistribution, and associated molecular responses in experimental tissue-remodeling models
Planning for long-term use, including the cost implications , is a practical necessity